These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 17452895

  • 1. No association of factor V Leiden, prothrombin G20210A, and MTHFR C677T gene polymorphisms with kidney allograft survival: a multicenter study.
    Meyer M, Laux G, Scherer S, Tran TH, Opelz G, Mytilineos J.
    Transplantation; 2007 Apr 27; 83(8):1055-8. PubMed ID: 17452895
    [Abstract] [Full Text] [Related]

  • 2. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.
    Yasa MH, Bolaman Z, Yukselen V, Kadikoylu G, Karaoglul AO, Batun S.
    Hepatogastroenterology; 2007 Apr 27; 54(77):1438-42. PubMed ID: 17708272
    [Abstract] [Full Text] [Related]

  • 3. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.
    Mueller T, Marschon R, Dieplinger B, Haidinger D, Gegenhuber A, Poelz W, Webersinke G, Haltmayer M.
    J Vasc Surg; 2005 May 27; 41(5):808-15. PubMed ID: 15886665
    [Abstract] [Full Text] [Related]

  • 4. Is screening for factor V Leiden and prothrombin G20210A mutations in renal transplantation worthwhile? Results of a large single-center U.K. study.
    Pherwani AD, Winter PC, McNamee PT, Patterson CC, Hill CM, Connolly JK, Maxwell AP.
    Transplantation; 2003 Aug 15; 76(3):603-5. PubMed ID: 12923451
    [Abstract] [Full Text] [Related]

  • 5. Factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T are not associated with coronary artery disease and type 2 diabetes mellitus in western Iran.
    Rahimi Z, Nomani H, Mozafari H, Vaisi-Raygani A, Madani H, Malek-Khosravi S, Parsian A.
    Blood Coagul Fibrinolysis; 2009 Jun 15; 20(4):252-6. PubMed ID: 19349859
    [Abstract] [Full Text] [Related]

  • 6. The prevalence of factor V Leiden (G1691A), prothrombin G20210A and methylenetetrahydrofolate reductase C677T mutations in Jordanian patients with beta-thalassemia major.
    Al-Sweedan SA, Jaradat S, Iraqi M, Beshtawi M.
    Blood Coagul Fibrinolysis; 2009 Dec 15; 20(8):675-8. PubMed ID: 19710606
    [Abstract] [Full Text] [Related]

  • 7. Association of corticosteroids and factor V, prothrombin, and MTHFR gene mutations with avascular osteonecrosis in renal allograft recipients.
    Celik A, Tekis D, Saglam F, Tunali S, Kabakci N, Ozaksoy D, Manisali M, Ozcan MA, Meral M, Gülay H, Camsari T.
    Transplant Proc; 2006 Mar 15; 38(2):512-6. PubMed ID: 16549163
    [Abstract] [Full Text] [Related]

  • 8. Thrombophilic polymorphisms - factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T - in Tunisian patients with cerebral venous thrombosis.
    Ben Salem-Berrabah O, Fekih-Mrissa N, N'siri B, Ben Hamida A, Benammar-Elgaaied A, Gritli N, Mrissa R.
    J Clin Neurosci; 2012 Sep 15; 19(9):1326-7. PubMed ID: 22721898
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis.
    Eroglu A, Egin Y, Cam R, Akar N.
    Ann Hematol; 2009 Jan 15; 88(1):73-6. PubMed ID: 18682947
    [Abstract] [Full Text] [Related]

  • 11. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease.
    Toydemir PB, Elhan AH, Tükün A, Toydemir R, Gürler A, Tüzüner A, Bökesoy I.
    J Rheumatol; 2000 Dec 15; 27(12):2849-54. PubMed ID: 11128675
    [Abstract] [Full Text] [Related]

  • 12. The frequency of factor V Leiden and concomitance of factor V Leiden with prothrombin G20210A mutation and methylene tetrahydrofolate reductase C677T gene mutation in healthy population of Denizli, Aegean region of Turkey.
    Kabukcu S, Keskin N, Keskin A, Atalay E.
    Clin Appl Thromb Hemost; 2007 Apr 15; 13(2):166-71. PubMed ID: 17456626
    [Abstract] [Full Text] [Related]

  • 13. Factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations among patients with sickle cell disease in Eastern Saudi Arabia.
    Fawaz NA, Bashawery L, Al-Sheikh I, Qatari A, Al-Othman SS, Almawi WY.
    Am J Hematol; 2004 Jul 15; 76(3):307-9. PubMed ID: 15224376
    [Abstract] [Full Text] [Related]

  • 14. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.
    Silingardi M, Salvarani C, Boiardi L, Accardo P, Iorio A, Olivieri I, Cantini F, Salvi F, La Corte R, Triolo G, Ciccia F, Ghirarduzzi A, Filippini D, Paolazzi G, Iori I.
    Arthritis Rheum; 2004 Apr 15; 51(2):177-83. PubMed ID: 15077257
    [Abstract] [Full Text] [Related]

  • 15. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients.
    Dölek B, Eraslan S, Eroğlu S, Kesim BE, Ulutin T, Yalçiner A, Laleli YR, Gözükirmizi N.
    Clin Appl Thromb Hemost; 2007 Oct 15; 13(4):435-8. PubMed ID: 17911197
    [Abstract] [Full Text] [Related]

  • 16. Significance of factor V, prothrombin, MTHFR, and PAI-1 genotypes in childhood cerebral thrombosis.
    Ozyurek E, Balta G, Degerliyurt A, Parlak H, Aysun S, Gürgey A.
    Clin Appl Thromb Hemost; 2007 Apr 15; 13(2):154-60. PubMed ID: 17456624
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population.
    Finan RR, Tamim H, Ameen G, Sharida HE, Rashid M, Almawi WY.
    Am J Hematol; 2002 Dec 15; 71(4):300-5. PubMed ID: 12447960
    [Abstract] [Full Text] [Related]

  • 18. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
    Almawi WY, Tamim H, Kreidy R, Timson G, Rahal E, Nabulsi M, Finan RR, Irani-Hakime N.
    J Thromb Thrombolysis; 2005 Jun 15; 19(3):189-96. PubMed ID: 16082606
    [Abstract] [Full Text] [Related]

  • 19. [C677T mutation in methylentetrahydrofolatereductase gene in patients with venous thromboses from the central region of Russia correlates with a high risk of pulmonary artery thromboembolism].
    Avdonin PV, Kirienko AI, Kozhevnikova LM, Shostak NA, Babadaeva NM, Leont'ev SG, Petukhov EB, Kubatiev AA, Savel'ev VS.
    Ter Arkh; 2006 Jun 15; 78(6):70-6. PubMed ID: 16881367
    [Abstract] [Full Text] [Related]

  • 20. MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risks factor for youth retinal vein occlusion.
    Cruciani F, Moramarco A, Curto T, Labate A, Recupero V, Conti L, Gandolfo GM, Balacco Gabrieli C.
    Clin Ter; 2003 Jun 15; 154(5):299-303. PubMed ID: 14994919
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.